RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Cytosorbents Stock

Cytosorbents Employees 2024

Cytosorbents Employees

151

Ticker

CTSO

ISIN

US23283X2062

WKN

A12GDU

In 2024, Cytosorbents employed 151 people, a 0% change from the 151 number of employees in the previous year.

Cytosorbents Aktienanalyse

What does Cytosorbents do?

Cytosorbents Corp is a US-American company specialized in the development of medical technologies for the treatment of life-threatening diseases and injuries. It was founded in 1997 by Dr. Phillip Chan. Originally, Cytosorbents specialized in the development of therapeutics for cancer therapy. After several development phases and a realignment of the company, they eventually focused on developing medical products for intensive care medicine. The business model of Cytosorbents is based on the development and marketing of blood purification systems that remove harmful substances and toxins from the blood. This can treat life-threatening diseases and complications such as sepsis, organ failure, or severe burns. An important product of Cytosorbents is the Cytosorb system, which consists of an extracorporeal blood purification device. The system is used to attenuate disease-related inflammatory reactions and remove harmful substances from the blood. This is intended to prevent complications and improve the survival of patients. Cytosorbents offers the Cytosorb system, among other things, for use in intensive and emergency medicine. It is used, among other things, to treat sepsis, which can lead to life-threatening organ failure. It is also used to treat severe burns, to rid the blood of toxic substances and inflammatory mediators, and thus accelerate the healing process. In addition to the Cytosorb system, the company also offers other medical products such as the HemoDefend plasma exchanger. This system is used to purify blood plasma from harmful substances while retaining the beneficial components in the plasma. It is used, among other things, to treat patients in need of a blood transfusion. Cytosorbents has experienced significant expansion in recent years. The company has established subsidiaries in Europe, Asia, and the Middle East and works closely with major hospitals and medical facilities. Additionally, the company has formed several partnerships with leading medical technology companies to expand the use of its technology in other areas. In summary, Cytosorbents is an innovative company specializing in the development of medical devices for the treatment of life-threatening diseases. The company has expanded significantly in recent years and collaborates with renowned hospitals and medical facilities. In the future, Cytosorbents will continue to refine and improve its technologies to help even more patients. Cytosorbents ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Employees Details

Examining Cytosorbents's Employee Base

Cytosorbents's employees are a pivotal aspect of its operations, driving innovation, productivity, and growth. The size and composition of the workforce offer insights into the company's scale, diversity, and investment in human capital. Analyzing employee trends and data is essential for understanding Cytosorbents's operational capacity and future potential.

Year-to-Year Comparison

Assessing Cytosorbents's employee numbers year-over-year helps in identifying growth patterns, expansions, or contractions. An increasing employee count can indicate scaling operations and investment in talent, while a decrease may signal efficiency improvements, automation, or business challenges.

Impact on Investments

Cytosorbents's employee data impacts investment decisions by shedding light on the company’s operational efficiency, innovation capability, and sustainability. Investors assess workforce data to gauge the firm's potential to execute strategies, innovate, and adapt to market changes effectively.

Interpreting Employee Trends

Fluctuations in Cytosorbents’s employee numbers indicate changes in business strategy, operational demands, and market dynamics. Investors and analysts scrutinize these trends to evaluate the company’s strategic positioning, adaptability, and potential for sustainable growth.

Frequently Asked Questions about Cytosorbents stock

How many employees does Cytosorbents have this year?

Cytosorbents has 151 undefined employees this year.

How many employees did Cytosorbents have compared to the previous year?

Compared to the previous year, Cytosorbents had 0% more employees.

What impact did the number of employees have on the company Cytosorbents?

The number of employees has a direct impact on the efficiency and productivity of Cytosorbents. A higher number of employees can indicate that the company is growing and has more resources to achieve its goals, while a lower number of employees may suggest that the company is saving costs or facing difficulties in recruiting new employees.

What impact did the number of employees have on investors of Cytosorbents?

The number of employees can also have an impact on investors of Cytosorbents, as it can be an indicator of the company's growth and financial health. A higher number of employees can promise investors, while a lower number of employees may raise concerns.

How does an increase in equity capital of Cytosorbents affect the company?

An increase in equity of Cytosorbents can improve the financial strength of the company and increase its ability to make future investments and fulfill obligations.

How does a reduction in Cytosorbents's equity affect the company?

A reduction in equity of Cytosorbents can impair its financial stability and decrease its ability to fulfill future investments and obligations.

What are some factors that influence the equity of Cytosorbents?

Some factors that can influence the equity of Cytosorbents include, among others, revenue development, profit and loss statement, dividend payments, and investments.

Why is the equity of Cytosorbents so important for investors?

The equity of Cytosorbents is important for investors as it is an indicator of the company's financial stability and provides investors with information on the amount of financial backing the company has in terms of obligations and future investments.

How does the number of employees at Cytosorbents influence the company?

The number of employees at Cytosorbents can directly impact the growth and performance of the company. A higher number of employees can lead to increased capacity and productivity, while a lower number of employees may result in reduced efficiency and limitations.

How has the number of employees at Cytosorbents evolved in recent years?

In recent years, the number of employees at Cytosorbents has changed by 0.

How many employees does Cytosorbents currently have?

Cytosorbents currently has 151 undefined employees.

Why is the number of employees important for investors of Cytosorbents?

The number of employees is important for investors of Cytosorbents as it is an indicator of the growth potential and performance of the company. It also provides information on how the company is able to manage and recruit its workforce.

What strategic measures can Cytosorbents take to change the number of employees?

To change the number of employees, Cytosorbents can take various measures such as adjusting compensation packages, improving working conditions, conducting recruitment campaigns, and promoting a positive corporate culture. It is important for the company to conduct a thorough assessment of its situation to determine the best strategic actions to change its number of employees.

How much dividend does Cytosorbents pay?

Over the past 12 months, Cytosorbents paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Cytosorbents is expected to pay a dividend of 0 USD.

What is the dividend yield of Cytosorbents?

The current dividend yield of Cytosorbents is .

When does Cytosorbents pay dividends?

Cytosorbents pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Cytosorbents?

Cytosorbents paid dividends every year for the past 0 years.

What is the dividend of Cytosorbents?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Cytosorbents located?

Cytosorbents is assigned to the 'Health' sector.

Wann musste ich die Aktien von Cytosorbents kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Cytosorbents from 11/16/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 11/16/2024.

When did Cytosorbents pay the last dividend?

The last dividend was paid out on 11/16/2024.

What was the dividend of Cytosorbents in the year 2023?

In the year 2023, Cytosorbents distributed 0 USD as dividends.

In which currency does Cytosorbents pay out the dividend?

The dividends of Cytosorbents are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

The Cytosorbents stock can be added to a savings plan with the following providers: Trade Republic

Andere Kennzahlen von Cytosorbents

Our stock analysis for Cytosorbents Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Cytosorbents Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.